Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.

ABSTRACT:

Purpose

To investigate the association between clinical PET (positron emission tomography) type and oncologic outcome in resectable pancreatic cancer.

Methods

Between January 2008 and October 2012, patients who underwent potentially curative resection for resectable pancreatic ductal adenocarcinoma without neoadjuvant treatment were retrospectively investigated. Clinical PET type was defined as follows: pancreatic cancer with similar 18FDG uptake to renal calyx was determined as kidney-type (K-type), and relatively lower 18FDG uptake than that of renal calyx was regarded as Non-K type.

Results

A total of 53 patients were enrolled. After agreement-based reclassification, agreement based K-type (aK-type) was noted in 34 patients (64.2%), and agreement based Non-K type (

SUBMITTER: Chong JU 

PROVIDER: S-EPMC5325284 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature